 Massachusetts
"Massachusetts" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
State bounded on the north by New Hampshire and Vermont, on the east by the Atlantic Ocean, on the south by Connecticut and Rhode Island, and on the west by New York.
| Descriptor ID |
D008404
|
| MeSH Number(s) |
Z01.107.567.875.550.510
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Massachusetts".
Below are MeSH descriptors whose meaning is more specific than "Massachusetts".
This graph shows the total number of publications written about "Massachusetts" by people in this website by year, and whether "Massachusetts" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 | | 1998 | 0 | 1 | 1 | | 1999 | 0 | 1 | 1 | | 2000 | 0 | 1 | 1 | | 2001 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 3 | 3 | | 2004 | 0 | 3 | 3 | | 2005 | 0 | 5 | 5 | | 2007 | 0 | 3 | 3 | | 2008 | 0 | 6 | 6 | | 2009 | 0 | 2 | 2 | | 2010 | 0 | 4 | 4 | | 2011 | 0 | 11 | 11 | | 2012 | 0 | 7 | 7 | | 2013 | 0 | 4 | 4 | | 2014 | 0 | 10 | 10 | | 2015 | 0 | 5 | 5 | | 2016 | 0 | 8 | 8 | | 2017 | 0 | 9 | 9 | | 2018 | 0 | 9 | 9 | | 2019 | 0 | 9 | 9 | | 2020 | 0 | 12 | 12 | | 2021 | 0 | 8 | 8 | | 2022 | 0 | 8 | 8 | | 2023 | 0 | 3 | 3 | | 2024 | 0 | 7 | 7 | | 2025 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Massachusetts" by people in Profiles.
-
Aris IM, Rifas-Shiman SL, Perng W, Yi L, de Ferranti SD, Hivert MF, Oken E. Trajectory of Cardiovascular Health Across Childhood and Adolescence. JAMA Cardiol. 2025 May 01; 10(5):417-426.
-
Lin Z, Rifas-Shiman SL, Perng W, Capotosto MP, Shifren JL, Joffe H, Hivert MF, Chavarro JE, Oken E, Aris IM. Neighborhood Vulnerability and Age of Natural Menopause and Menopausal Symptoms Among Midlife Women. JAMA Netw Open. 2025 May 01; 8(5):e2512075.
-
Barocas JA, Aldridge A, Adkins KF, Barbosa C, Battaglia TA, Bush J, Castry M, Corry G, Clarke T, El-Bassel N, Figueroa W, Freedman DA, Freisthler B, Gibbons B, Gibson EB, Glasgow L, Harlow K, Huerta TR, Hunt T, Johnson R, Larimore E, Linas BP, Luckey JM, Montoya I, Murphy SM, Oga E, Onuoha E, Orme S, Ryan D, Schackman BR, Seiber EE, Singer M, Speer D, Starbird L, Tin Y, Villani J, Walsh SL, Watson C, Zarkin GA, McCollister K. An economic analysis of community costs incurred to implement the communities that HEAL intervention to reduce opioid overdose deaths in four states. Drug Alcohol Depend. 2025 Jul 01; 272:112671.
-
Perng W, Fitz VW, Salmon K, Hivert MF, Kazemi M, Rifas-Shiman SL, Shifren J, Oken E, Chavarro JE. Prevalence and correlates of diagnosed and probable polycystic ovary syndrome (PCOS) in a cohort of parous women. Am J Epidemiol. 2025 Jan 08; 194(1):114-121.
-
Anyane-Yeboa A, Bermudez H, Fredericks M, Yoguez N, Ibekwe-Agunanna L, Daly J, Hildebrant E, Kuckreja M, Hindin R, Pelton-Cairns L, Karnes LS, Kruse GR, Gundersen DA, Emmons KM. The revised colorectal cancer screening guideline and screening burden at community health centers. Sci Rep. 2025 01 02; 15(1):336.
-
Barocas JA, Erdman EA, Westfall MY, Christine PJ, Bernson D, Villani J, Doogan NJ, White L, Walley AY, Bettano A, Wang J. Prevalence of adults with stimulant misuse and/or stimulant use disorder in Massachusetts, USA, 2014-2021. Addiction. 2025 Apr; 120(4):711-720.
-
Castry M, Tin Y, Feder NM, Lewis N, Chatterjee A, Rudorf M, Samet JH, Beers D, Medley B, Gilbert L, Linas BP, Barocas JA. An economic analysis of the cost of mobile units for harm reduction, naloxone distribution, and medications for opioid use disorder. J Subst Use Addict Treat. 2024 Dec; 167:209517.
-
Christine PJ, Chahine RA, Kimmel SD, Mack N, Douglas C, Stopka TJ, Calver K, Fanucchi LC, Slavova S, Lofwall M, Feaster DJ, Lyons M, Ezell J, Larochelle MR. Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements. JAMA Netw Open. 2024 08 01; 7(8):e2425999.
-
Christine PJ, Goldman AL, Morgan JR, Yan S, Chatterjee A, Bettano AL, Binswanger IA, LaRochelle MR. Insurance Instability for Patients With Opioid Use Disorder in the Year After Diagnosis. JAMA Health Forum. 2024 Jul 05; 5(7):e242014.
-
Yamkovoy K, Patil P, Dunn D, Erdman E, Bernson D, Swathi PA, Nall SK, Zhang Y, Wang J, Brinkley-Rubinstein L, LeMasters KH, White LF, Barocas JA. Using decision tree models and comprehensive statewide data to predict opioid overdoses following prison release. Ann Epidemiol. 2024 Jun; 94:81-90.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|